Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Patent
1994-06-08
1996-04-16
Springer, David B.
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
548507, 548495, 548253, 548118, C07D20920, C07D40312, A61K 3141, A61K 31405
Patent
active
055084320
ABSTRACT:
CCK modulators, e.g. agonists or antagonists, of the following formula (I): ##STR1## or a base-addtion salt thereof.
REFERENCES:
patent: 4490364 (1984-12-01), Rivier
Horwell, et al. J. Med. Chem. 1991, 34, 404-401 "Rationally Designed `Dipeptoid` Analogues of CCK. .alpha.-Methyltryptophan Derivatives as Highly Selective and Orally Active Gastrin and CCK-B antagonists with Potent Anxiolytic Properties".
Jensen, et al. Biochem. Biophys. Acta. 1983, 757, 250-258 "COOH-Terminal Fragments of Cholecystokinin--A New Class of Cholecystokinin Receptor Antagonists".
Spanarke., et al. J. Bio. Chem. 1983, vol. 258, 11, 6746-6749 "Cholecystokinin-27-32-Amide".
Shiosake, et al. J. Med. Chem. 1990, 33, 2950-2952 "Development of CCK-Tetrapeptide Analogues as Potent and Selective CCK-A Receptor Agonists".
Drysdale, et al. J. Med. Chem. 1992, 35, 2573-2581 "Rationally Designed `Dipeptoid` Analogues of CCK. Acid Mimics of the Potent and Selective Non-Peptide CCK-B Receptor Antagonist Cl-988".
Dezube Milana
Hirst Gavin C.
Sugg Elizabeth E.
Dadswell Charles E.
Glaxo Wellcome Inc.
Springer David B.
LandOfFree
Modulators of cholecystokinin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modulators of cholecystokinin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulators of cholecystokinin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-326358